金吾财讯 | 创新药板块走高，诺诚健华(09969)涨10.98%，歌礼制药-B(01672)涨8.36%，联邦制药(03933)涨4.83%，科伦博泰生物-B(06990)涨3.52%，乐普生物-B(02157)涨2.77%，康哲药业(00867)涨2.29%，先声药业(02096)涨2.18%，晶泰控股(02228)涨2.22%，康诺亚-B(02162)涨1.73%。消息面上，近日召开的2026年全国药品注册管理和上市后监管工作会议透露，“十五五”期间，国家药监局将大力支持生物制造产业创新发展，推动医药产业由“跟随式创新”向“系统性创新”转型，由“规模速度型增长”向“质量效益型增长”转型，由“传统商业模式”向“供应链数字化”转型。国家药监局相关负责人表示，2025年全年我国共有76个创新药获批上市，研发应用居全球领先水平。目前，生物医药创新呈现前沿技术复杂化、创新主体多元化、监管标准国际化三大趋势，我国审评审批标准与国际标准体系深度对接，既提升国产创新药的全球竞争力，也吸引了国际创新成果来到中国“首发”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.